• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of novel PET tracers with long half-lives using for tumor diagnosis

Research Project

Project/Area Number 24591824
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Radiation science
Research InstitutionSuzuka University of Medical Science

Principal Investigator

IIDA YASUHIKO  鈴鹿医療科学大学, 薬学部, 教授 (60252425)

Research Collaborator FUJISAWA YUTAKA  鈴鹿医療科学大学, 薬学部, 助手 (30511993)
Project Period (FY) 2012-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
KeywordsPET診断 / がん診断 / ヘマトポルフィリン / 放射性薬剤 / Cu-64 / PET
Outline of Final Research Achievements

For positron emission tomography (PET) diagnosis, we usually use four β+ emitters, 11C, 13N, 15O, and 18F. However, these radionuclides cannot allow us to take enough time of radiopharmaceuticals synthesis, preparation or delivering due to their short half-lives from 2 to 110 minutes. Therefore, the development of novel PET tracers with longer half-lives would be contributed to releasing from such time restrictions and enlarging PET utilities. 64Cu is a β+ emitter with long half-life (12.8hr) and it has a suitable property for labeling of various PET tracers. In this study, we planned to develop novel PET tracers labeled with 64Cu using for tumor diagnosis, and synthesized 64Cu labeled Hematoporphyrin (HP) and its derivatives (HPDs). Hematoporphyrin has been widely used as photosensitizer in photodynamic therapy and can specifically accumulate in tumors. We evaluated their potentials as PET tracers for tumor diagnosis in mice bearing MDA-MB-231 human breast cancer cells.

Report

(5 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (7 results)

All 2015 2014 2013 2012

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 1 results,  Acknowledgement Compliant: 1 results) Presentation (4 results)

  • [Journal Article] Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography.2015

    • Author(s)
      Yamaguchi A, Hanaoka H, Fujisawa Y, Zhao S, Suzue K, Morita A, Tominaga H, Higuchi T, Hisaeda H, Tsushima Y, Kuge Y, Iida Y.
    • Journal Title

      EJNMMI Res.

      Volume: 5 Issue: 1 Pages: 29-29

    • DOI

      10.1186/s13550-015-0109-z

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Imaging P-glycoprotein Function in Rats Using [11C]-N-desmethyl-loperamide.2013

    • Author(s)
      Michael Farwell, Derek Chong, Yasuhiko Iida, Sung A Bae, Balu Easwaramoorthy, Masanori Ichise.
    • Journal Title

      Ann Nucl Med.

      Volume: 27 Issue: 7 Pages: 618-624

    • DOI

      10.1007/s12149-013-0725-5

    • NAID

      10031194483

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy2012

    • Author(s)
      Yoshioka H, Yamamoto S, Hanaoka H, Iida Y, Paudyal P, Higuchi T, Tominaga H, Oriuchi N, Nakagawa H, Shiba Y, Yoshida K, Osawa R, Katagiri T, Tsunoda T, Nakamura Y, Endo K
    • Journal Title

      Cancer Immunol Immunother

      Volume: 61 Issue: 8 Pages: 1211-1220

    • DOI

      10.1007/s00262-011-1186-0

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Tumor imaging with 64Cu labeled Hematoporphyrin derivatives in MDA-MB-231 bearing mice.2014

    • Author(s)
      Fujisawa Y., Yamaguchi A., Mineta M., Nakasuka A., Tominaga H., Higuchi T., Tsushima Y., Hashimoto K., Nagai Y., Iida Y.
    • Organizer
      EANM'14 - Annual Congress of the European Association of Nuclear Medicine.
    • Place of Presentation
      Gothenburg, Sweden
    • Year and Date
      2014-10-18 – 2014-10-22
    • Related Report
      2014 Research-status Report
  • [Presentation] ヒト乳腺がん細胞移入マウスにおける64Cu標識Hematoporphyrin誘導体の腫瘍集積性評価2014

    • Author(s)
      藤澤豊、峰田麻衣子、中須賀彩、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      薬学会第134年会
    • Place of Presentation
      熊本県熊本市
    • Related Report
      2013 Research-status Report
  • [Presentation] DA-MB-231移入マウスにおける64Cu標識ヘマトポルフィリンの腫瘍集積性評価2013

    • Author(s)
      中須賀彩、藤澤豊、峰田麻衣子、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      第59回日本薬学会東海支部大会
    • Place of Presentation
      愛知県名古屋市
    • Related Report
      2013 Research-status Report
  • [Presentation] MDA-MB-231移入マウスにおける64Cu標識ヘマトポルフィリンの腫瘍集積性評価2013

    • Author(s)
      中須賀彩、藤澤豊、峰田麻衣子、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      第59回日本薬学会東海支部 総会・大会
    • Place of Presentation
      名古屋
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi